VRXAW — Veraxa Biotech Holding AG
—
Nasdaq ·
Health Care ·
Pharmaceuticals ·
CIK 2079109 ·
Switzerland
Last close
—
Market Cap
—
52W High
—
52W Low
—
ADV30
—
Next earnings
—
No quarterly fundamentals indexed for this ticker.
Peers — same industry
| Ticker | Name | Market Cap | Last | Daily % |
|---|---|---|---|---|
| LLY | ELI LILLY & Co | $1.02T | $1148.84 | — |
| JNJ | JOHNSON & JOHNSON | $617.78B | $256.35 | — |
| ABBV | AbbVie Inc. | $443.36B | $250.94 | — |
| MRK | Merck & Co., Inc. | $321.57B | $130.20 | — |
| NVSEF | NOVARTIS AG | $301.30B | $158.52 | — |
News headlines (Yahoo Finance, 1h cache)
VERAXA Biotech (VRXA) Strengthens Scientific Leadership as New CSO Takes the Helm in Advancing BiTAC(R) Cancer Therapy Platform
2026-07-30 18:15 · Yahoo
VERAXA Biotech (VRXA) Expands Patent Portfolio to Support Next-Generation Cancer Therapy Platforms
2026-07-29 19:30 · Yahoo
VERAXA Biotech Strengthens Patent Portfolio to Protect Core Technology Platforms and Product Candidates
2026-07-29 11:00 · Yahoo
VERAXA Biotech (VRXA) Shareholders Approve Corporate Governance, Financing Measures
2026-07-28 17:45 · Yahoo
VERAXA Biotech (VRXA) Advances Bispecific ADC Program Under OmniAb Collaboration
2026-07-27 19:37 · Yahoo
VERAXA Biotech Announces Advancement of Novel Bispecific Antibody Drug Conjugate Program VXA-222 from Joint Discovery Collaboration with OmniAb
2026-07-27 11:00 · Yahoo
VERAXA Biotech Shareholders Approve All Proposals at Extraordinary General Meeting, Strengthening Strategic Flexibility for Future Growth
2026-07-24 20:05 · Yahoo
VERAXA Biotech AG (VRXA) Appoints Christoph Erkel as Chief Scientific Officer
2026-07-24 18:30 · Yahoo
VERAXA Biotech (VRXA) Advances BiTAC(R)-TCE Development With Positive Regulatory Feedback From Germany
2026-07-23 18:30 · Yahoo
VERAXA Biotech Appoints Christoph Erkel as Chief Scientific Officer to Advance BiTAC® Technology Platforms and Portfolio
2026-07-23 11:00 · Yahoo
Recent Insider Activity
No insider activity indexed for this ticker.